Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Cancer Science: Using Embryonic Stem Cells to Test Breast Cancer Genes
Sara Hartley, MDLinx Oncology
Technology Advances: Nanotech PSA Levels Unmask Lingering Prostate Cancer
Dorothy J. Schirf, MD, MDLinx Oncology
Need help assessing patients for generic risk factors for hemophilia? Check out our free CME, fresh from ISTH 2009.
Victoria Luken, MDLinx CME
  See all

Articles: Dermatologic Oncology



Latest (3) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma
Journal of Clinical Oncology, 05/15/09
Sponsor
Targeted radionuclide therapy of melanoma: Anti-tumoural efficacy studies of a new 131I labelled potential agent
International Journal of Cancer, 05/15/09
LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
European Journal of Cancer, 05/15/09
Antifolate Activity of Pyrimethamine Enhances Temozolomide-Induced Cytotoxicity in Melanoma Cells
Molecular Cancer Research, 05/15/09
Adjuvant therapy with pegylated interferon alfa-2b vs observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group
Journal of Clinical Oncology, 05/13/09    Evidence Based Medicine
Exclusive Author Commentary
Paediatric HIV-related skin diseases
Diagnostic Histopathology, 05/12/09
A Controlled Trial of Objective Measures of Sunscreen and Moisturizing Lotion
Cancer Epidemiology, Biomarkers & Prevention, 05/11/09
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma
Clinical Cancer Research, 05/05/09
A new pulsed electric field therapy for melanoma disrupts the tumors blood supply and causes complete remission without recurrence
International Journal of Cancer, 05/05/09
Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
Clinical Cancer Research, 05/04/09
Serum Amyloid A As a Prognostic Marker in Melanoma Identified by Proteomic Profiling
Journal of Clinical Oncology, 05/01/09
Season of diagnosis has no effect on survival from malignant melanoma
International Journal of Cancer, 04/30/09
Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation
Pathology, 04/30/09
Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression
Histopathology, 04/29/09
Acquired reactive perforating collagenosis with the histological features of IgG4-related sclerosing disease in a patient with Mikuliczs disease
Pathology International, 04/29/09
TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas
Modern Pathology, 04/28/09
Cutaneous melanoma mortality starting to change: A study of trends in Northern Ireland
European Journal of Cancer, 04/28/09
The efficacy of facial skin cancer treatment with high-energy pulsed neodymium and Nd:YAG lasers
Photomedicine and Laser Surgery, 04/27/09
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia (ATLL) causing skin erosions
Blood, 04/27/09    Evidence Based Medicine
Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential
Proceedings of the National Academy of Sciences of the United States of America, 04/24/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
250 Available Pages
First    Prev    10      11      12      13      14      15      16      17      18      19      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.